Latest news
Shelling in Hormuz Pushes Brent Crude Back to $83! Energy Corridor Risk Premium Heats Up Again as Oil Bulls Regain Pricing Power - BitgetBitget · Fri, 07 Aug 2026 07:35:58 GMTTurning tumors into "in situ vaccines"! Replimune (REPL.US) oncolytic virus passes FDA, bringing a new generation of immune reactivation strategies for PD-1 resistant melanoma - BitgetBitget · Thu, 06 Aug 2026 23:21:11 GMTREPLIMUNE GROUP INC : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $17.00 FROM $11.00 - BitgetBitget · Tue, 04 Aug 2026 19:54:13 GMTReplimune RP1 melanoma BLA wins favorable 10-3 FDA advisory panel vote on IGNYTE efficacy data - BitgetBitget · Thu, 30 Jul 2026 07:00:00 GMT